• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Doximity Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    4/17/26 4:34:16 PM ET
    $DOCS
    EDP Services
    Technology
    Get the next $DOCS alert in real time by email
    docs-20260413
    0001516513FALSE00015165132026-04-132026-04-13

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    _________________________________________________________________________________________________________________
    FORM 8-K
    _________________________________________________________________________________________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): April 13, 2026
    _________________________________________________________________________________________________________________
    Doximity, Inc.
    (Exact Name of Registrant as Specified in Its Charter)
    _________________________________________________________________________________________________________________
    Delaware
    001-40508
    27-2485512
    (State or Other Jurisdiction of Incorporation)
    (Commission File Number)
    (I.R.S. Employer Identification Number)
    500 3rd St.
    Suite 510
    San Francisco, CA 94107
    (Address of principal executive offices, including zip code)
    (650) 549-4330
    (Registrant's telephone number, including area code)
    _______________________________________________________________________________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Class A common stock, $0.001 par value per share
    DOCS
    The New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 5.02 - Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

    As previously disclosed by Doximity, Inc. (the “Company”) on February 5, 2026, Anna Bryson, the Company’s Chief Financial Officer, had been on medical leave. On April 13, 2026, the Company accepted her resignation as Chief Financial Officer. Effective February 3, 2026, the Company’s Board of Directors appointed Siddharth Sitaram, the Company’s Chief Accounting Officer, to serve as the Company’s interim principal financial officer and interim principal accounting officer. Mr. Sitaram will continue in that role until a new Chief Financial Officer is appointed. The Company expects to provide an update regarding the status of its Chief Financial Officer search during its next earnings call.

    Item 7.01 - Regulation FD Disclosure

    The Company is reaffirming its guidance for the fourth quarter and full fiscal year ending March 31, 2026, as originally provided in the Company’s earnings release and conference call on February 5, 2026.
    The information in this Item 7.01 of this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
    Use of Forward-Looking Statements
    Statements we make in this Current Report on Form 8-K may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) our ability to successfully identify and recruit a permanent Chief Financial Officer; (ii) the potential disruption to our business and operations resulting from executive leadership transitions; (iii) the timing and scope of anticipated stock repurchases; (iv) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (v) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (vi) our ability to attract new customers or retain existing customers; (vii) the impact of our prioritization of our members’ interests; (viii) breaches in our security measures or unauthorized access to members’ data; (ix) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and our upcoming Annual Report on Form 10-K for the fiscal year ended March 31, 2026, to be filed with the SEC, and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this report relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    Date: April 17, 2026
    DOXIMITY, INC.
    By:
    /s/ John T. Vaughan
    John T. Vaughan
    General Counsel and Corporate Secretary


    Get the next $DOCS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOCS

    DatePrice TargetRatingAnalyst
    4/8/2026$25.00Outperform → In-line
    Evercore ISI
    2/9/2026$34.00Hold → Buy
    Canaccord Genuity
    2/6/2026$40.00Underweight → Neutral
    Analyst
    1/20/2026$55.00Equal Weight → Overweight
    Wells Fargo
    1/9/2026$59.00Outperform
    RBC Capital Mkts
    1/8/2026Hold → Buy
    Truist
    12/15/2025$65.00Equal-Weight → Overweight
    Morgan Stanley
    12/9/2025$63.00Overweight
    Barclays
    More analyst ratings

    $DOCS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Doximity downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Doximity from Outperform to In-line and set a new price target of $25.00

    4/8/26 8:28:57 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Doximity from Hold to Buy and set a new price target of $34.00

    2/9/26 6:58:22 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by Analyst with a new price target

    Analyst upgraded Doximity from Underweight to Neutral and set a new price target of $40.00

    2/6/26 8:05:27 AM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sitaram Siddharth

    4 - Doximity, Inc. (0001516513) (Issuer)

    4/14/26 5:56:08 PM ET
    $DOCS
    EDP Services
    Technology

    Interim PFO and PAO Sitaram Siddharth converted options into 5,000 shares and sold $58,833 worth of shares (2,319 units at $25.37), increasing direct ownership by 3% to 84,132 units (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    3/12/26 8:59:59 PM ET
    $DOCS
    EDP Services
    Technology

    Interim PFO and PAO Sitaram Siddharth converted options into 5,000 shares and sold $63,622 worth of shares (2,282 units at $27.88), increasing direct ownership by 3% to 81,451 units (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    3/12/26 8:58:52 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist

    94% of physicians are using AI or interested, but 71% are concerned about its accuracy and reliability Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today released a new report examining how physicians are adopting artificial intelligence (AI) in clinical practice. The findings show that AI adoption and interest are widespread: 94% of physicians reported they are currently using AI or interested in doing so. At the same time, physicians remain cautious, with 71% citing accuracy and reliability as their top concern. "AI has quickly become a meaningful part of physicians' daily workflows," said Amit Phull, MD, chief clinical experience officer at

    3/17/26 6:00:00 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive Year

    Doximity Dialer earns A-level ratings in all categories Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named the #1 Telehealth Video Conferencing Platform in the 2026 Best in KLAS Report. This is the fifth consecutive year that Doximity has earned the top spot, underscoring its position as a trusted, long-term partner for physicians and health systems. In addition to securing the #1 spot, Doximity received A-level ratings in all categories, including A+ ratings for culture, loyalty and value. These results are based on live interviews with health system leaders and their staff, reflecting high satisf

    2/5/26 4:05:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026

    Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2025 after market close on February 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu

    1/15/26 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    SEC Filings

    View All

    Doximity Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - Doximity, Inc. (0001516513) (Filer)

    4/17/26 4:34:16 PM ET
    $DOCS
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.

    SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)

    3/26/26 6:06:21 PM ET
    $DOCS
    EDP Services
    Technology

    SEC Form 10-Q filed by Doximity Inc.

    10-Q - Doximity, Inc. (0001516513) (Filer)

    2/5/26 4:09:11 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Financials

    Live finance-specific insights

    View All

    Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026

    Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2025 after market close on February 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu

    1/15/26 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025

    Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2025 after market close on November 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inc

    10/16/25 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity Acquires Pathway, a Leader in AI Clinical Reference

    $63M acquisition brings physician AI team and datasets to Doximity's AI suite Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway's team. Over the past seven years, they've assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway's model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (

    8/7/25 4:02:00 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Leadership Updates

    Live Leadership Updates

    View All

    Parspec Raises $20 Million Series A to Modernize the Construction Supply Chain with AI

    SAN MATEO, Calif., July 8, 2025 /PRNewswire/ -- Parspec, an AI-native software platform that enables wholesale distributors and sales agents to efficiently bid and supply construction products, today announced it has raised $20 million in Series A funding. The round was led by Threshold Ventures (formerly DFJ), with participation from existing venture investors including Innovation Endeavors, Building Ventures, Heartland Ventures, and Hometeam Ventures. Parspec Raises $20 Million Series A to Modernize the Construction Supply Chain with AIThe global construction industry repres

    7/8/25 9:30:00 AM ET
    $BOX
    $DOCS
    $RELY
    Computer Software: Prepackaged Software
    Technology
    EDP Services
    Real Estate

    Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

    With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

    9/26/24 6:05:00 AM ET
    $DOCS
    $RELY
    $LVGO
    EDP Services
    Technology
    Real Estate
    Computer Software: Programming, Data Processing

    Doximity Appoints Phoebe Yang to Its Board of Directors

    Experienced director and executive brings health system and cloud expertise SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced the appointment of Phoebe L. Yang to its Board of Directors. Ms. Yang has been General Manager at Amazon Web Services, Healthcare, and a member of the board of directors for CommonSpirit Health, one of the largest U.S. health systems. Ms. Yang is a long-time member of the Council on Foreign Relations, and has served as an appointee in two Presidential Administrations. In 2021, she was named one of Modern Healthcare's Top 100 Most Influential People in Healthcare and one

    8/4/22 4:02:00 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Doximity Inc.

    SC 13G/A - Doximity, Inc. (0001516513) (Subject)

    11/14/24 5:22:01 PM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by Doximity Inc.

    SC 13G - Doximity, Inc. (0001516513) (Subject)

    11/14/24 11:42:53 AM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by Doximity Inc.

    SC 13G - Doximity, Inc. (0001516513) (Subject)

    11/12/24 9:55:17 AM ET
    $DOCS
    EDP Services
    Technology